ICHCC/LinkedIn
May 30, 2026, 10:17
Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
Iranian Comprehensive Hemophilia Care Center (ICHCC) shared a post on LinkedIn:
“Factor X deficiency, or Stuart-Prower factor deficiency:
- is an ultra-rare bleeding disorder caused by a lack or dysfunction of Factor X—a critical protein required for blood clotting. Affecting about 1 in 500,000 to a million people, it can be inherited genetically or acquired later in life.
- Symptoms and ComplicationsSeverity is generally classified by the amount of circulating Factor X in the blood:Mild (40% – 60% of normal): Easy bruising, mild nose or mouth bleeds, and bleeding after trauma or surgery.Moderate (10% – 40% of normal): Spontaneous minor bleeds, heavy periods, or prolonged bleeding after dental procedures.Severe (<10% of normal): High risk of spontaneous, life-threatening hemorrhages (such as intracranial bleeds), joint/muscle bleeds, and umbilical cord bleeding in newborns.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026